Low-dose aspirin does not affect the progression of age-related hearing loss

FHS
July 30, 2024
9:24 am

The effect of daily low-dose aspirin versus placebo on the progression of age-related hearing loss in healthy older adults.

What to know about Alnylam’s upcoming readout on its heart drug

Next week, the biopharma world will see eagerly awaited results from a trial that could shape care for patients with an increasingly common heart condition

August 20, 2024

European drug regulator rejects Alzheimer’s drug Leqembi, citing safety concerns

The European Medicines Agency on Friday held its ground against anti-amyloid treatments, saying it will not recommend Eisai and Biogen’s Alzheimer’s drug Leqembi for approval

July 27, 2024

Intuitive execs cast wary eye on potential Trump tariffs

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q4 revenue: $2.41 billion

January 24, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.